Literature DB >> 16945460

Cytotoxic effects of S-(dimethylarsino)-glutathione: a putative intermediate metabolite of inorganic arsenicals.

Seishiro Hirano1, Yayoi Kobayashi.   

Abstract

Glutathione (GSH) plays an important role in the metabolism of arsenite and arsenate by generating arsenic-glutathione complexes. Although dimethylarsinic acid (DMA(V)) is the major metabolite of inorganic arsenicals (iAs) in urine, it is not clear how DMA(V) is produced from iAs. In the present study we report that S-(dimethylarsino)-glutathione (DMA(III)(SG)), a putative precursor of dimethylarsinic acid DMA(V), was unstable in the culture medium without excess GSH and generated volatile substances which were highly cytotoxic for both rat heart microvascular endothelial cells and HL60, a human leukemia cell line. Cytotoxicity of DMA(III)(SG) was higher than that of iAs and its LC(50) value was calculated to be 7.8 microM in the endothelial cells. To our surprise DMA(III)(SG) effectively killed cells in the neighbor wells of the same multi-well dish, indicating that volatile toxic compounds generated from DMA(III)(SG) in the culture medium. High performance lipid chromatography-inductively coupled plasma mass spectrometry (HPLC-ICPMS) analyses suggested that the freshly generated volatile compounds dissolved into aqueous solution and formed an unstable arsenic compound and the unstable compound was further converted to DMA(V). These results suggested that DMA(III)(SG) exerts its cytotoxicity by generating volatile arsenicals and is implicated in the metabolic conversion of inorganic arsenicals into DMA(V), a major final metabolite of inorganic arsenicals in most mammals.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16945460     DOI: 10.1016/j.tox.2006.07.009

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  4 in total

1.  Speciation, formation, stability and analytical challenges of human arsenic metabolites.

Authors:  Lucy Yehiayan; Mahesh Pattabiraman; Konstantinos Kavallieratos; Xiaotang Wang; Lawrence H Boise; Yong Cai
Journal:  J Anal At Spectrom       Date:  2009-07-21       Impact factor: 4.023

2.  The novel organic arsenical darinaparsin induces MAPK-mediated and SHP1-dependent cell death in T-cell lymphoma and Hodgkin lymphoma cells and human xenograft models.

Authors:  Dashnamoorthy Ravi; Savita Bhalla; Ronald B Gartenhaus; Jennifer Crombie; Irawati Kandela; Jaya Sharma; Andrew Mazar; Andrew M Evens
Journal:  Clin Cancer Res       Date:  2014-10-14       Impact factor: 12.531

3.  Standardization of [F-18]FDG PET/CT for response evaluation by the Radiologic Society of North America-Quantitative Imaging Biomarker Alliance (RSNA-QIBA) profile: preliminary results from the Japan-QIBA (J-QIBA) activities for Asian international multicenter phase II trial.

Authors:  Hyeyeol Bae; Junichi Tsuchiya; Takehito Okamoto; Ikuko Ito; Yusuke Sonehara; Fumiko Nagahama; Kazunori Kubota; Ukihide Tateishi
Journal:  Jpn J Radiol       Date:  2018-09-24       Impact factor: 2.374

4.  Dimethylarsinothioyl glutathione as a metabolite in human multiple myeloma cell lines upon exposure to Darinaparsin.

Authors:  Lucy Yehiayan; Szabina Stice; Guangliang Liu; Shannon Matulis; Lawrence H Boise; Yong Cai
Journal:  Chem Res Toxicol       Date:  2014-03-26       Impact factor: 3.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.